Unibest 优贝德
← Back to patent-cliff list

双氯芬酸钠

Tier C — Watch / trade

Diclofenac Sodium

诺华制药
Originator
1974
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type

Targets:COXs

Brand:ProSorb-D、Abitren、Rectos、Dicloreum CR、Dimethaid-D、Voltarol Ophtha、Dicloabak、Voltarène、Voltaren gel、Zorvolex、Pennsaid、Feitas Z、Instanac TPM、Naboal、Pennsaid Gel、Pennsaid Viscous Solution、Voltaren Ofta、Voltaren Tape L、Dyloject、Diclofelite CR、Voveran、Dynapar、DicloFoam、Voltaren、Voltaren Tape、Doroxan、Voltaren lotion、Voltarol、Pennsaid Plus、Dealgic

Indications (approved):骨关节炎、类风湿关节炎、强直性脊柱炎

Regional status

US
临床二期
2009-09-01
EU
批准上市
1974-01-11
China
批准上市
1988-01-01
Japan
批准上市
1974-02-01

Synthetic routes & intermediates

Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.

Frequently asked questions

What are the approved indications of Diclofenac Sodium?

Approved indications include: 骨关节炎, 类风湿关节炎, 强直性脊柱炎.

When does the Diclofenac Sodium patent expire?

No public expiry year is available for Diclofenac Sodium yet; this page updates once verified.

How do I get a quote for Diclofenac Sodium intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-25